BIONET Balance Sheet Health
Financial Health criteria checks 5/6
BIONET has a total shareholder equity of NT$1.8B and total debt of NT$40.0M, which brings its debt-to-equity ratio to 2.3%. Its total assets and total liabilities are NT$2.5B and NT$689.0M respectively. BIONET's EBIT is NT$81.4M making its interest coverage ratio -5. It has cash and short-term investments of NT$998.2M.
Key information
2.3%
Debt to equity ratio
NT$40.00m
Debt
Interest coverage ratio | -5x |
Cash | NT$998.19m |
Equity | NT$1.77b |
Total liabilities | NT$688.95m |
Total assets | NT$2.46b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 1784's short term assets (NT$1.4B) exceed its short term liabilities (NT$366.6M).
Long Term Liabilities: 1784's short term assets (NT$1.4B) exceed its long term liabilities (NT$322.3M).
Debt to Equity History and Analysis
Debt Level: 1784 has more cash than its total debt.
Reducing Debt: 1784's debt to equity ratio has increased from 0% to 2.3% over the past 5 years.
Debt Coverage: 1784's debt is well covered by operating cash flow (437%).
Interest Coverage: 1784 earns more interest than it pays, so coverage of interest payments is not a concern.